T

Serial Number 79386129
Registration 7772609
700

Registration Progress

Application Filed
Nov 14, 2023
Under Examination
Approved for Publication
Mar 11, 2025
Published for Opposition
Mar 11, 2025
Registered
Apr 29, 2025

Trademark Image

T

Basic Information

Serial Number
79386129
Registration Number
7772609
Filing Date
November 14, 2023
Registration Date
April 29, 2025
Published for Opposition
March 11, 2025
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Apr 29, 2025
Registration
Registered
Classes
005 009 010 042
+1 more

Rights Holder

Telix Pharmaceuticals Limited

99
Address
Level 4, 55 Flemington Road
North Melbourne VIC 3051
AU

Ownership History

Telix Pharmaceuticals Limited

Original Applicant
99
AU

Telix Pharmaceuticals Limited

Owner at Publication
99
AU

Telix Pharmaceuticals Limited

Original Registrant
99
AU

Legal Representation

Attorney
Andrew S. Ehard

USPTO Deadlines

Next Deadline
1951 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20250429)
Due Date
April 29, 2031
Grace Period Ends
October 29, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

38 events
Date Code Type Description Documents
Dec 5, 2025 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Nov 15, 2025 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Nov 14, 2025 FIMP P FINAL DISPOSITION PROCESSED Loading...
Jul 29, 2025 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Jun 13, 2025 OPNX P NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Loading...
May 27, 2025 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
May 27, 2025 OPNR P NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Loading...
Apr 29, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Apr 29, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 11, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 11, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 5, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 18, 2025 ALIE A ASSIGNED TO LIE Loading...
Feb 13, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 13, 2025 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Feb 13, 2025 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Feb 13, 2025 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Feb 13, 2025 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Feb 13, 2025 ZZZX Z PREVIOUS ALLOWANCE COUNT WITHDRAWN Loading...
Feb 11, 2025 PBCR Z WITHDRAWN FROM PUB - OG REVIEW QUERY Loading...
Jan 27, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 27, 2025 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jan 27, 2025 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jan 27, 2025 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Jan 27, 2025 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jan 26, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 2, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 2, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 2, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 1, 2024 RFNT P REFUSAL PROCESSED BY IB Loading...
Apr 6, 2024 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Apr 6, 2024 RFRR P REFUSAL PROCESSED BY MPU Loading...
Mar 19, 2024 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Mar 18, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 14, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 2, 2024 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Dec 29, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 28, 2023 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of cancer; Chemical preparations for pharmaceutical purposes, namely, diagnostic radiopharmaceutical preparations; Contrast media for use with medical equipment; Diagnostic agents for medical use in in vivo scanning; Compositions for medical use, namely, chemical products for pharmaceutical use, namely, chemical preparations for the prevention, diagnosis, treatment or improvement of conditions and disorders, namely, cancer; Chemicals for pharmaceutical use for the treatment, prevention, or diagnosis of cancer
Class 009
Downloadable computer operating software; Downloadable computer application software for mobile phones, portable media players, and handheld computers, namely, software for the treatment, prevention, or diagnosis of cancer; Software as a Medical Device (SaMD), downloadable, for the treatment, prevention, or diagnosis of cancer; Downloadable computer programs for medical purposes, namely, for the treatment, prevention, or diagnosis of cancer; Downloadable computer programs for the treatment, prevention, or diagnosis of cancer
Class 010
Apparatus for administering pharmaceuticals for the treatment, prevention, or diagnosis of cancer, namely, medical apparatus for introducing pharmaceutical preparations into the human body for the treatment, prevention, or diagnosis of cancer; apparatus for medical purposes for the treatment, prevention, or diagnosis of cancer, namely, injection needles, injection syringes, and radiological apparatus for the treatment, prevention, or diagnosis of cancer; medical apparatus for the treatment of cancer; applicators for pharmaceutical preparations, namely, applicators for pharmaceutical preparations sold without medication; pharmaceutical instruments, namely, radiological apparatus for medical purposes, medical apparatus for the treatment of cancer and diseases associated with cellular proliferation, and imaging apparatus for medical use for diagnosing medical conditions; medical apparatus for use in laparoscopy; Medical apparatus for detecting cancer; Surgical instruments and apparatus; detecting instruments for medical use for detecting cancer; Medical instruments for use in the treatment, prevention, or diagnosis of cancer; Test equipment for medical use, namely, medical diagnostic instrument for cancer; diagnostic imaging apparatus for medical use; medical imaging apparatus; Probes for medical purposes; surgical instruments in the nature of surgical probes; surgical robots; nanorobots for medical purposes for surgical use
Class 042
Software as a service (SAAS) services featuring software for the treatment, prevention, or diagnosis of cancer; computer software design; computer software development; computer software programming services for others in the field of medicine; development of software for the treatment, prevention, or diagnosis of cancer; Software as a service (SAAS) services, namely, hosting software for use by others for the treatment, prevention, or diagnosis of cancer; installation of computer software; software creation in the nature of computer software design; software engineering services; Design and writing of computer software; online provision of web-based applications, namely, providing temporary use of on-line non-downloadable applications for the treatment, prevention, and diagnosis of cancer; online provision of web-based software, namely, providing temporary use of online non-downloadable software for the treatment, prevention, or diagnosis of cancer; Consultancy in the field of artificial intelligence technology; research in the field of artificial intelligence technology
Class 044
Medical analysis services for the diagnosis and treatment of persons with cancer; medical analysis services relating to the treatment of persons; medical diagnostic services; medical health assessment services; services for the preparation of medical reports, namely, providing medical information to patients, in the form of reports in the field of cancer; advisory services relating to medical services; consultancy and advisory services in relation to medical services; provision of medical information; Consulting services in the field of healthcare; health screening services in the field of cancer; providing information relating to health care services; preparation of reports relating to health care matters for medical purposes

Additional Information

Design Mark
The mark consists of four blue triangles facing inward to form a circle containing a stylized lowercase letter "T". There is a blue circle in the center of the four triangles. The color white serves as background areas and is not claimed as a feature of the mark.
Color Claim
The color blue is claimed as a feature of the mark.
Pseudo Mark
TELIX

Classification

International Classes
005 009 010 042 044